Home | News | Oxford, AstraZeneca resume vaccine trial
AstraZeneca headquarters in Sydney. Photo: NCA NewsWire/Bianca De Marchi

Oxford, AstraZeneca resume vaccine trial

The University of Oxford has announced it is resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a UK patient.

Please login below to view content or register for a 4 week FREE Trial.

Membership Login

Get the news delivered straight to your inbox

Receive the top stories in our weekly newsletter Sign up now